B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus

ABSTRACT Objective To determine the value of lymphocyte subsets and granulocyte/monocyte surface markers in predicting the risk of post‐acute pancreatitis diabetes (PPDM‐A). Methods This study included 308 in patients with acute pancreatitis (AP). The markers of granulocytes and monocytes and lympho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes 2025-01, Vol.17 (1), p.e70047-n/a
Hauptverfasser: Lin, Xiaoyan, Li, Xiaoling, Wang, Junsheng, Liu, Huiheng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page e70047
container_title Journal of diabetes
container_volume 17
creator Lin, Xiaoyan
Li, Xiaoling
Wang, Junsheng
Liu, Huiheng
description ABSTRACT Objective To determine the value of lymphocyte subsets and granulocyte/monocyte surface markers in predicting the risk of post‐acute pancreatitis diabetes (PPDM‐A). Methods This study included 308 in patients with acute pancreatitis (AP). The markers of granulocytes and monocytes and lymphocyte subsets were detected by flow cytometry, and the fluorescence intensity, absolute count and percentage were obtained. Based on the occurrence of diabetes after AP, patients were divided into two groups: PPDM‐A and PPNG‐A (post‐acute pancreatitis with normal glucose). Correlations between granulocyte and monocyte surface markers and lymphocyte subsets were analyzed. Binary logistic regression was used to analyze the potential influencing factors of PPDM‐A. Results Compared with patients with PPNG‐A, patients with PPDM‐A tend to be younger (p 
doi_str_mv 10.1111/1753-0407.70047
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11725652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3160213942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3037-65236c0f8c5aa06d37a657bd03ff56f40309a9b58522060de19ef74affc4c8503</originalsourceid><addsrcrecordid>eNqFkb1u2zAUhYmgRX6czN0KAV2y2L4URVKaCuevdeEiHpKZoCnSZiCLDkkl8JZHyJAnzJNEqh2jzVIuJO79eO49OAh9wTDA7RliTkkfMuADDpDxPXS4q3x6f5OCHKCjEO4AGGeM7KMDUuSAMcsO0c1ZMlkvVwun1lG_Pr2Mkql389qFaFUyrkurZHQ-sXUybWuvT88j1USdTGWtvJbRRhuSCytnOuqQ_NZVZWMTjtFnI6ugT7Z3D91eXd6c_-xPrn-Mz0eTviJAeJ_RlDAFJldUSmAl4ZJRPiuBGEOZyYBAIYsZzWmaAoNS40IbnkljVKZyCqSHvm90V81sqUul6-hlJVbeLqVfCyet-LdT24WYuweBMU9pN76HTrcK3t03OkSxtEG1NmStXRMEwTTL84ICb9FvH9A71_i69ddSDFJMiqwTHG4o5V0IXpvdNhhEF5noQhFdQOJPZO2Pr3-b2PHvGbUA3QCPttLr_-mJXxdnG-E3dfuiAg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3160213942</pqid></control><display><type>article</type><title>B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Lin, Xiaoyan ; Li, Xiaoling ; Wang, Junsheng ; Liu, Huiheng</creator><creatorcontrib>Lin, Xiaoyan ; Li, Xiaoling ; Wang, Junsheng ; Liu, Huiheng</creatorcontrib><description>ABSTRACT Objective To determine the value of lymphocyte subsets and granulocyte/monocyte surface markers in predicting the risk of post‐acute pancreatitis diabetes (PPDM‐A). Methods This study included 308 in patients with acute pancreatitis (AP). The markers of granulocytes and monocytes and lymphocyte subsets were detected by flow cytometry, and the fluorescence intensity, absolute count and percentage were obtained. Based on the occurrence of diabetes after AP, patients were divided into two groups: PPDM‐A and PPNG‐A (post‐acute pancreatitis with normal glucose). Correlations between granulocyte and monocyte surface markers and lymphocyte subsets were analyzed. Binary logistic regression was used to analyze the potential influencing factors of PPDM‐A. Results Compared with patients with PPNG‐A, patients with PPDM‐A tend to be younger (p &lt; 0.001) and have a higher proportion of fatty liver, recurrent pancreatitis, and hyperlipidemic pancreatitis. The results of linear regression showed that B% was negatively correlated with MFI of HLA‐DR on monocytes (R2 = 0.145, p &lt; 0.001), B% was positively correlated with CD10−NEUT% (R2 = 0.291, p &lt; 0.001), and MFI of HLA‐DR on monocytes was negatively correlated with CD10−NEUT% (R2 = 0.457, p &lt; 0.001). Multivariate logistic regression analysis revealed that age, serous effusion, fatty liver, recurrent pancreatitis, and B% were independent risk factors for the occurrence of PPDM‐A. Conclusion Our study has first confirmed the correlation between PPDM‐A and lymphocyte subsets and CD10−NEUT%. Furthermore we indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The mechanism of granulocyte and monocyte surface markers and B lymphocytes on PPDM‐A is worthy of study. This would help clarify the pathogenesis of PPDM‐A at the cellular level and potentially provide new strategies for immunotherapy and even disease prevention. [Correction added on 24 January 2025, after first online publication: the third subtitle in section has been changed to ‘Results’.] In this study, we aimed to determine the value of lymphocyte subsets and granulocyte/monocyte markers in predicting the risk of post‐acute pancreatitis diabetes mellitus (PPDM‐A). Our study is the first to confirm the correlation between PPDM‐A and lymphocyte subsets and indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The interaction mechanism of granulocyte and monocyte surface markers and B lymphocytes on glucose metabolism disorder after AP is worthy of further study.</description><identifier>ISSN: 1753-0393</identifier><identifier>ISSN: 1753-0407</identifier><identifier>EISSN: 1753-0407</identifier><identifier>DOI: 10.1111/1753-0407.70047</identifier><identifier>PMID: 39801164</identifier><language>eng</language><publisher>Melbourne: Wiley Publishing Asia Pty Ltd</publisher><subject>Acute Disease ; Adult ; Aged ; B-Lymphocytes - immunology ; Biomarkers - blood ; CD10 ; Diabetes ; Diabetes Mellitus - blood ; Female ; Flow Cytometry ; Granulocytes ; HLA‐DR ; Humans ; Lymphocytes ; Male ; MFI ; Middle Aged ; Monocytes ; Original ; Pancreatitis ; Pancreatitis - blood ; Pancreatitis - complications ; Pancreatitis - immunology ; PPDM‐A ; PPNG‐A ; Prognosis ; Regression analysis ; Risk Factors</subject><ispartof>Journal of diabetes, 2025-01, Vol.17 (1), p.e70047-n/a</ispartof><rights>2025 The Author(s). published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2025 The Author(s). Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</rights><rights>2025. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3037-65236c0f8c5aa06d37a657bd03ff56f40309a9b58522060de19ef74affc4c8503</cites><orcidid>0000-0002-0017-2158</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725652/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725652/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39801164$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Xiaoyan</creatorcontrib><creatorcontrib>Li, Xiaoling</creatorcontrib><creatorcontrib>Wang, Junsheng</creatorcontrib><creatorcontrib>Liu, Huiheng</creatorcontrib><title>B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus</title><title>Journal of diabetes</title><addtitle>J Diabetes</addtitle><description>ABSTRACT Objective To determine the value of lymphocyte subsets and granulocyte/monocyte surface markers in predicting the risk of post‐acute pancreatitis diabetes (PPDM‐A). Methods This study included 308 in patients with acute pancreatitis (AP). The markers of granulocytes and monocytes and lymphocyte subsets were detected by flow cytometry, and the fluorescence intensity, absolute count and percentage were obtained. Based on the occurrence of diabetes after AP, patients were divided into two groups: PPDM‐A and PPNG‐A (post‐acute pancreatitis with normal glucose). Correlations between granulocyte and monocyte surface markers and lymphocyte subsets were analyzed. Binary logistic regression was used to analyze the potential influencing factors of PPDM‐A. Results Compared with patients with PPNG‐A, patients with PPDM‐A tend to be younger (p &lt; 0.001) and have a higher proportion of fatty liver, recurrent pancreatitis, and hyperlipidemic pancreatitis. The results of linear regression showed that B% was negatively correlated with MFI of HLA‐DR on monocytes (R2 = 0.145, p &lt; 0.001), B% was positively correlated with CD10−NEUT% (R2 = 0.291, p &lt; 0.001), and MFI of HLA‐DR on monocytes was negatively correlated with CD10−NEUT% (R2 = 0.457, p &lt; 0.001). Multivariate logistic regression analysis revealed that age, serous effusion, fatty liver, recurrent pancreatitis, and B% were independent risk factors for the occurrence of PPDM‐A. Conclusion Our study has first confirmed the correlation between PPDM‐A and lymphocyte subsets and CD10−NEUT%. Furthermore we indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The mechanism of granulocyte and monocyte surface markers and B lymphocytes on PPDM‐A is worthy of study. This would help clarify the pathogenesis of PPDM‐A at the cellular level and potentially provide new strategies for immunotherapy and even disease prevention. [Correction added on 24 January 2025, after first online publication: the third subtitle in section has been changed to ‘Results’.] In this study, we aimed to determine the value of lymphocyte subsets and granulocyte/monocyte markers in predicting the risk of post‐acute pancreatitis diabetes mellitus (PPDM‐A). Our study is the first to confirm the correlation between PPDM‐A and lymphocyte subsets and indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The interaction mechanism of granulocyte and monocyte surface markers and B lymphocytes on glucose metabolism disorder after AP is worthy of further study.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>B-Lymphocytes - immunology</subject><subject>Biomarkers - blood</subject><subject>CD10</subject><subject>Diabetes</subject><subject>Diabetes Mellitus - blood</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Granulocytes</subject><subject>HLA‐DR</subject><subject>Humans</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>MFI</subject><subject>Middle Aged</subject><subject>Monocytes</subject><subject>Original</subject><subject>Pancreatitis</subject><subject>Pancreatitis - blood</subject><subject>Pancreatitis - complications</subject><subject>Pancreatitis - immunology</subject><subject>PPDM‐A</subject><subject>PPNG‐A</subject><subject>Prognosis</subject><subject>Regression analysis</subject><subject>Risk Factors</subject><issn>1753-0393</issn><issn>1753-0407</issn><issn>1753-0407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNqFkb1u2zAUhYmgRX6czN0KAV2y2L4URVKaCuevdeEiHpKZoCnSZiCLDkkl8JZHyJAnzJNEqh2jzVIuJO79eO49OAh9wTDA7RliTkkfMuADDpDxPXS4q3x6f5OCHKCjEO4AGGeM7KMDUuSAMcsO0c1ZMlkvVwun1lG_Pr2Mkql389qFaFUyrkurZHQ-sXUybWuvT88j1USdTGWtvJbRRhuSCytnOuqQ_NZVZWMTjtFnI6ugT7Z3D91eXd6c_-xPrn-Mz0eTviJAeJ_RlDAFJldUSmAl4ZJRPiuBGEOZyYBAIYsZzWmaAoNS40IbnkljVKZyCqSHvm90V81sqUul6-hlJVbeLqVfCyet-LdT24WYuweBMU9pN76HTrcK3t03OkSxtEG1NmStXRMEwTTL84ICb9FvH9A71_i69ddSDFJMiqwTHG4o5V0IXpvdNhhEF5noQhFdQOJPZO2Pr3-b2PHvGbUA3QCPttLr_-mJXxdnG-E3dfuiAg</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Lin, Xiaoyan</creator><creator>Li, Xiaoling</creator><creator>Wang, Junsheng</creator><creator>Liu, Huiheng</creator><general>Wiley Publishing Asia Pty Ltd</general><general>John Wiley &amp; Sons, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0017-2158</orcidid></search><sort><creationdate>202501</creationdate><title>B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus</title><author>Lin, Xiaoyan ; Li, Xiaoling ; Wang, Junsheng ; Liu, Huiheng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3037-65236c0f8c5aa06d37a657bd03ff56f40309a9b58522060de19ef74affc4c8503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>B-Lymphocytes - immunology</topic><topic>Biomarkers - blood</topic><topic>CD10</topic><topic>Diabetes</topic><topic>Diabetes Mellitus - blood</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Granulocytes</topic><topic>HLA‐DR</topic><topic>Humans</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>MFI</topic><topic>Middle Aged</topic><topic>Monocytes</topic><topic>Original</topic><topic>Pancreatitis</topic><topic>Pancreatitis - blood</topic><topic>Pancreatitis - complications</topic><topic>Pancreatitis - immunology</topic><topic>PPDM‐A</topic><topic>PPNG‐A</topic><topic>Prognosis</topic><topic>Regression analysis</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Xiaoyan</creatorcontrib><creatorcontrib>Li, Xiaoling</creatorcontrib><creatorcontrib>Wang, Junsheng</creatorcontrib><creatorcontrib>Liu, Huiheng</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Xiaoyan</au><au>Li, Xiaoling</au><au>Wang, Junsheng</au><au>Liu, Huiheng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus</atitle><jtitle>Journal of diabetes</jtitle><addtitle>J Diabetes</addtitle><date>2025-01</date><risdate>2025</risdate><volume>17</volume><issue>1</issue><spage>e70047</spage><epage>n/a</epage><pages>e70047-n/a</pages><issn>1753-0393</issn><issn>1753-0407</issn><eissn>1753-0407</eissn><abstract>ABSTRACT Objective To determine the value of lymphocyte subsets and granulocyte/monocyte surface markers in predicting the risk of post‐acute pancreatitis diabetes (PPDM‐A). Methods This study included 308 in patients with acute pancreatitis (AP). The markers of granulocytes and monocytes and lymphocyte subsets were detected by flow cytometry, and the fluorescence intensity, absolute count and percentage were obtained. Based on the occurrence of diabetes after AP, patients were divided into two groups: PPDM‐A and PPNG‐A (post‐acute pancreatitis with normal glucose). Correlations between granulocyte and monocyte surface markers and lymphocyte subsets were analyzed. Binary logistic regression was used to analyze the potential influencing factors of PPDM‐A. Results Compared with patients with PPNG‐A, patients with PPDM‐A tend to be younger (p &lt; 0.001) and have a higher proportion of fatty liver, recurrent pancreatitis, and hyperlipidemic pancreatitis. The results of linear regression showed that B% was negatively correlated with MFI of HLA‐DR on monocytes (R2 = 0.145, p &lt; 0.001), B% was positively correlated with CD10−NEUT% (R2 = 0.291, p &lt; 0.001), and MFI of HLA‐DR on monocytes was negatively correlated with CD10−NEUT% (R2 = 0.457, p &lt; 0.001). Multivariate logistic regression analysis revealed that age, serous effusion, fatty liver, recurrent pancreatitis, and B% were independent risk factors for the occurrence of PPDM‐A. Conclusion Our study has first confirmed the correlation between PPDM‐A and lymphocyte subsets and CD10−NEUT%. Furthermore we indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The mechanism of granulocyte and monocyte surface markers and B lymphocytes on PPDM‐A is worthy of study. This would help clarify the pathogenesis of PPDM‐A at the cellular level and potentially provide new strategies for immunotherapy and even disease prevention. [Correction added on 24 January 2025, after first online publication: the third subtitle in section has been changed to ‘Results’.] In this study, we aimed to determine the value of lymphocyte subsets and granulocyte/monocyte markers in predicting the risk of post‐acute pancreatitis diabetes mellitus (PPDM‐A). Our study is the first to confirm the correlation between PPDM‐A and lymphocyte subsets and indicated that age, fatty liver, serous effusion, recurrent AP, and B% were independent risk factors for PPDM‐A. The interaction mechanism of granulocyte and monocyte surface markers and B lymphocytes on glucose metabolism disorder after AP is worthy of further study.</abstract><cop>Melbourne</cop><pub>Wiley Publishing Asia Pty Ltd</pub><pmid>39801164</pmid><doi>10.1111/1753-0407.70047</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0017-2158</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1753-0393
ispartof Journal of diabetes, 2025-01, Vol.17 (1), p.e70047-n/a
issn 1753-0393
1753-0407
1753-0407
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11725652
source MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Acute Disease
Adult
Aged
B-Lymphocytes - immunology
Biomarkers - blood
CD10
Diabetes
Diabetes Mellitus - blood
Female
Flow Cytometry
Granulocytes
HLA‐DR
Humans
Lymphocytes
Male
MFI
Middle Aged
Monocytes
Original
Pancreatitis
Pancreatitis - blood
Pancreatitis - complications
Pancreatitis - immunology
PPDM‐A
PPNG‐A
Prognosis
Regression analysis
Risk Factors
title B Lymphocyte—A Prognostic Indicator in Post‐Acute Pancreatitis Diabetes Mellitus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T01%3A54%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=B%20Lymphocyte%E2%80%94A%20Prognostic%20Indicator%20in%20Post%E2%80%90Acute%20Pancreatitis%20Diabetes%20Mellitus&rft.jtitle=Journal%20of%20diabetes&rft.au=Lin,%20Xiaoyan&rft.date=2025-01&rft.volume=17&rft.issue=1&rft.spage=e70047&rft.epage=n/a&rft.pages=e70047-n/a&rft.issn=1753-0393&rft.eissn=1753-0407&rft_id=info:doi/10.1111/1753-0407.70047&rft_dat=%3Cproquest_pubme%3E3160213942%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3160213942&rft_id=info:pmid/39801164&rfr_iscdi=true